Igiinc Also Known As Ichnos Glenmark Innovationis A Global Biotechnology Company Based In New York Citywith Research And Manufacturing Sites In Switzerlandthe Company Is Dedicated To Developing Innovative Biologics For Oncologyfocusing On Treatments For Hematological Malignancies And Solid Tumors Igi Utilizes Its Proprietary Beatatechnology Platform To Create Novel Multispecific Immune Cell Engagers And Modulatorsthe Companyae S Pipeline Features First In Class Multispecificsa C Designed To Address Complex Diseases Comprehensivelythrough Its Collaboration With Glenmark Pharmaceuticals Ltd Igi Combines Expertise In Novel Biologics And Small Molecules To Enhance Drug Discovery In Cancer Treatment Led By Cyril Kontom D Igi Has A Skilled Management Team And Employs Around 250 Peoplethe Company Operates Centers Of Innovation In The Usaswitzerlandand Indiaemphasizing Its Commitment To Advancing Cancer Therapies
